NanoViricides
NNVC
$2.04
Share price
-3.32%
Change (1 day)
-57.14%
Change (1 year)
Categories
Revenue for NanoViricides (NNVC)
Revenue in : N/A
.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NanoViricides from to
Annual revenue
| Year | Revenue | Change |
|---|
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $27.47 B | inf% | 🇺🇸 USA |
 Merck MRK | $53.97 B | inf% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $46.46 B | inf% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $49.09 B | inf% | 🇬🇧 UK |
 Novavax NVAX | $1.30 B | inf% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.18 B | inf% | 🇺🇸 USA |